Yuanbo Hu

925 citations
35 papers · 590 indexed · h-index 13
Topics
Ferroptosis and cancer prognosis (5 papers)RNA modifications and cancer (5 papers)Cancer Genomics and Diagnostics (4 papers)
Journals
SHILAP Revista de lepidopterologíaNano LettersAdvanced Functional Materials
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Yuanbo Hu

33 papers receiving 583 citations

Peers

Yuanbo Hu
Comparison fields: 5 of 83
  • Molecular Biology 350
  • Cancer Research 221
  • Oncology 133
  • Pulmonary and Respiratory Medicine 132
  • Immunology 77
Replace Claudia Corrò with:
Claudia Corrò Switzerland
Wensheng Qiu China
Ignas Masilionis United States
Xiangsheng Yang China
James Patrick Heiserman United States
Jin-Fen Xiao United States
Hecheng Zhu China
Azadeh Azizian Germany
Martin Scherzer Austria
Junxiang Wen China
Yuanbo Hu relative to Claudia Corrò Switzerland Claudia Corrò's profile →
Citations per field
00.5×1.5×2.0×
Claudia Corrò · 1×
Citations per year

Countries citing papers authored by Yuanbo Hu

Since Specialization
Citations

This map shows the geographic impact of Yuanbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanbo Hu more than expected).

Fields of papers citing papers by Yuanbo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanbo Hu. The network helps show where Yuanbo Hu may publish in the future.

Co-authorship network of co-authors of Yuanbo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanbo Hu. A scholar is included among the top collaborators of Yuanbo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanbo Hu. Yuanbo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 2
4 4
5 6
6 15
7 2
8 13
9 29
10 17
11 154
12 30
13 4
14 9
15 8
16 15
17 13
18 13
19 9
20 0

About Yuanbo Hu

Yuanbo Hu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 35 papers that have together received 590 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (221 citations), Molecular Biology (350 citations) and Oncology (133 citations). Yuanbo Hu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Wen Huang, Qianhui Xu, Xian Shen, Chenbin Chen, Sian Chen, Xiangyang Xue, Xinya Tong, Xiangwei Sun, Bujian Pan and Xianjing Hu. Their work appears in journals such as SHILAP Revista de lepidopterología, Nano Letters and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026